The Antithrombotic Effects of Nitric Oxide

  • Joseph Loscalzo
Part of the NATO ASI Series book series (NSSA, volume 294)

Abstract

Nitric oxide (NO) is a free radical product of the endothelial cell that maintains blood flow. These effects of NO are the direct consequence of its ability to relax vascular smooth muscle and to inhibit platelet activation and platelet-dependent thrombus formation. In concert with prostacyclin, the other important endothelial product that regulates vessel tone and inhibits platelet function, endothelial NO serves to optimize tissue perfusion under a variety of physiologic and pathophysiologic conditions.

Keywords

Nitric Oxide Myosin Light Chain Kinase Antithrombotic Effect Fibrinogen Binding Actomyosin ATPase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Mendelsohn, M.E., O’Neill, S., George, D., and Loscalzo, J. Inhibition of fibrinogen binding to human platelets by S-nitroso-N-acetylcysteine. J. Biol. Chem., 265:19028–19034, 1990.PubMedGoogle Scholar
  2. 2.
    Nishikawa, M., DeLanerolle, P., Lincoln, T.M., and Adelstein, R.S. Phosphorylation of mammalian myosin light chain kinases by the catalytic subunit of cyclic AMP-dependent protein kinase and by cyclic GMP-dependent protein kinase. J. Biol. Chem., 259:8429–8436, 1984.PubMedGoogle Scholar
  3. 3.
    Ikebe, M. and Reardon, S. Phosphorylation of myosin light chain kinase by smooth muscle calcium/calmodulin-dependent multi-functional protein kinase. J. Biol Chem., 265:8975–8978, 1990.PubMedGoogle Scholar
  4. 4.
    Ignarro, U. and Kadowitz, P.J. A pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu. Rev. Pharmacol. Toxicol., 25:171–191, 1985.PubMedCrossRefGoogle Scholar
  5. 5.
    Pigazzi, A., Heydrick, S., Folli, F., and Loscalzo, J. Thrombin stimulates phosphoinositide 3-kinase-associated protein kinase activity in human platelets. J. Invest. Med., 44:214A, 1996.Google Scholar
  6. 6.
    Radomski, M.W., Palmer, R.M.J., and Moncada, S. Endogenous nitric oxide inhibits human platelet adhesion to the vascular endothelium. Lancet, 2:1057–1058, 1987.PubMedCrossRefGoogle Scholar
  7. 7.
    Michelson, A.D., Benoit, S.E., Furman, M.I., Breckwoldt, W.L., Rohrer, M.J., Barnard, M.R., and Loscalzo J. Effects of endothelium-derived relaxing factor/nitric oxide on platelet surface glycoproteins. Am. J. Physiol., 270:H1640–H1648, 1996.PubMedGoogle Scholar
  8. 8.
    Lieberman, E.H., O’Neill, S., and Mendelsohn, M.E. S-nitrosocysteine inhibition of human platelet secretion is correlated with increases in platelet cGMP levels. Circ. Res., 68:1722–1728, 1991.PubMedCrossRefGoogle Scholar
  9. 9.
    Keaney, J.F., Stamler, J.S., Simon, D.I., Jaraki, O., and Loscalzo, J. S-nitros-bovine serum albumin: An NO adduct with EDRF-like properties. J. Clin. Invest., 91:1582–1589, 1993.PubMedCrossRefGoogle Scholar
  10. 10.
    Simon, D.I., Stamler, J.S., Loh, E., Loscalzo, J., Francis, S.A., and Creager, M.A. Effect of nitric oxide synthase inhibition on bleeding time in humans. J. Cardiovasc. Pharm., 26:339–342, 1995.CrossRefGoogle Scholar
  11. 11.
    Folts, J.D., Stamler, J., and Loscalzo, J. Intravenous nitroglycerin infusion inhibits cyclic blood flow responses caused by periodic platelet thrombus formation in stenosed canine coronary arteries. Circulation, 83:2122–2127, 1991.PubMedCrossRefGoogle Scholar
  12. 12.
    Keaney J.F., Stamler, J.S., Scharfstein, J., Folts, J.D., and Loscalzo, J. NO forms a stable adduct with serum albumin that has potent antiplatelet properties in vivo. Clin. Res., 40:194A, 1992.Google Scholar
  13. 13.
    Pigazzi, A., Fabian, A., Johnson, J., Upchurch, G.R., Loscalzo, J. Identification of nitric oxide synthases in human megakaryocytes and platelets. Circulation, 92:1–365, 1995.CrossRefGoogle Scholar
  14. 14.
    Lelchuk, R., Radomski, M.W., Martin, J.F., and Moncada, S. Constitutive and inducible nitric oxide synthases in human megakaryoblastic cells. J. Pharmacol. Exp. Therap., 262:1220–1224, 1992.Google Scholar
  15. 15.
    Freedman, J.E., Alpert, C., Piedad, B., and Loscalzo, J. Nitric oxide production by platelets alters platelet recruitment to the platelet thrombus. J. Invest. Med., 44:328A, 1996.Google Scholar
  16. 16.
    Stamler, J., Mendelsohn, M., Amarante, P., Smick, D., George, D., and Loscalzo, J. N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ. Res., 65:789–795, 1989.PubMedCrossRefGoogle Scholar
  17. 17.
    Loscalzo, J. N-acetylcysteine markedly potentiates the inhibition of platelet aggregation by nitroglycerin. J. Clin. Invest., 76:703–708, 1985.PubMedCrossRefGoogle Scholar
  18. 18.
    Stamler, J.S., Jaraki, O., Osborne, J., Keaney Jr., J.F., Vita, J.A., Singel, D.J., Valeri, C.R., and Loscalzo, J. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc. Natl. Acad. Sci. (USA), 89:7674–7677, 1992.CrossRefGoogle Scholar
  19. 19.
    Stamler, J.S., Singel, D.J., Loscalzo, J. Biochemistry of nitric oxide and its redoxactived forms. Science, 251:1898–1901, 1992.CrossRefGoogle Scholar
  20. 20.
    Marks, D.S., Vita, J.A., Folts, J.D., Keaney Jr., J.F., Welch, G.N., and Loscalzo, J. Inhibition of neointimal proliferation in rabbits following vascular injury by a single treatment with a protein adduct of nitric oxide. J. Clin. Invest., 96:2630–2638, 1996.CrossRefGoogle Scholar
  21. 21.
    Shultz, P.H. and Raij, L. Endogenously synthesized nitric oxide prevents endotoxin-induced gomerular thrombosis. J. Clin. Invest., 90:1718–1725, 1992.PubMedCrossRefGoogle Scholar
  22. 22.
    Freedman, J.E., Loscalzo, J., Benoit, S.E., Valeri, C.R., Barnard, M.R., and Michelson, A.D. Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis. J. Clin. Invest., 97:979–987, 1996.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Joseph Loscalzo
    • 1
  1. 1.Whitaker Cardiovascular Institute and Evans Department of MedicineBoston University School of MedicineBostonUSA

Personalised recommendations